salmeterol xinafoate has been researched along with Cardiomyopathy, Congestive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhary, AS; Robinson, GM | 1 |
| Dunn, NR; Freemantle, SN; Mann, RD; Martin, RM | 1 |
2 other study(ies) available for salmeterol xinafoate and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Can beta agonists cause dilated cardiomyopathy?
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Cardiomyopathy, Dilated; Fluticasone; Humans; Male; Middle Aged; Radiography; Salmeterol Xinafoate | 2009 |
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.
Topics: Adrenergic beta-Agonists; Adult; Adverse Drug Reaction Reporting Systems; Aged; Albuterol; Anti-Asthmatic Agents; Cardiomyopathy, Dilated; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nedocromil; Risk; Salmeterol Xinafoate; Terbutaline; Time Factors | 1998 |